1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Vasomotor Symptoms of Menopause-Pipeline Insights, 2015

Summary


DelveInsight’s, Vasomotor Symptoms of Menopause- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Vasomotor Symptoms of Menopause. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Vasomotor Symptoms of Menopause Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

DelveInsight’s, Vasomotor Symptoms of Menopause- Pipeline Insights, 2015 Report covers the Vasomotor Symptoms of Menopause pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides Vasomotor Symptoms of Menopause related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for Vasomotor Symptoms of Menopause.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Scope


- DelveInsight’s report provides a Vasomotor Symptoms of Menopause Landscape across the globe
- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information
- Coverage of the Vasomotor Symptoms of Menopause pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
- The report reviews key players involved in the therapeutics development for Vasomotor Symptoms of Menopause and also provide company profiling
- Pipeline products coverage based on various stages of development from NDA filings to discovery.
- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


Reasons to Buy


- Complete Pipeline intelligence and complete understanding over therapeutics development for Vasomotor Symptoms of Menopause
- Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine.
- Track your competitors and develop strategic initiatives to support your drug development activities.
- Optimize your portfolio and keep you in touch with the rapidly changing pharmaceutical markets, and make the best decisions for your business.
- Understand the market and choose right partners for in-licensing and out licensing for your valuable assets
- Understand the factors behind failed/discontinued projects and move ahead without leaving any stone unturned

Table Of Contents

Vasomotor Symptoms of Menopause-Pipeline Insights, 2015
List of Tables

List of Tables
• Number of Products under Development for Vasomotor Symptoms of Menopause, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Vasomotor Symptoms of Menopause Assessment by Monotherapy Products
• Vasomotor Symptoms of Menopause Assessment by Combination Products
• Vasomotor Symptoms of Menopause Assessment by Route of Administration
• Vasomotor Symptoms of Menopause Assessment by Stage and Route of Administration
• Vasomotor Symptoms of Menopause Assessment by Molecule Type
• Vasomotor Symptoms of Menopause Assessment by Stage and Molecule Type
• Vasomotor Symptoms of Menopause Therapeutics - Discontinued Products
• Vasomotor Symptoms of Menopause Therapeutics - Dormant Products
• Products under Development by Companies, 2015


List of Figures

List of Figures
• Number of Products under Development for Vasomotor Symptoms of Menopause, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Vasomotor Symptoms of Menopause Assessment by Monotherapy Products
• Vasomotor Symptoms of Menopause Assessment by Combination Products
• Vasomotor Symptoms of Menopause Assessment by Route of Administration
• Vasomotor Symptoms of Menopause Assessment by Stage and Route of Administration
• Vasomotor Symptoms of Menopause Assessment by Molecule Type
• Vasomotor Symptoms of Menopause Assessment by Stage and Molecule Type

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
HPLC Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

HPLC Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

  • $ 5800
  • Industry report
  • October 2016
  • by Laboratory Markets Limited

This market report provides a comprehensive and easy-to-review analysis of the analytical HPLC market 2016 to 2020, providing key market data and identifying new and emerging opportunities across this ...

Label-free Array Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Label-free Array Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • December 2016
  • by Transparency Market Research

Global Label-free Array Systems: Overview Label-free array systems are used in the drug discovery industry by pharmaceutical and biotechnology companies, and work on the principles of optical interferometry, ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.